|
1
|
Smyth EC, Nilsson M, Grabsch HI, van
Grieken NC and Lordick F: Gastric cancer. Lancet. 396:635–648.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Qin Y, Tong X, Fan J, Liu Z, Zhao R, Zhang
T, Suo C, Chen X and Zhao G: Global burden and trends in incidence,
mortality, and disability of stomach cancer from 1990 to 2017. Clin
Transl Gastroenterol. 12:e004062021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cancer Genome Atlas Research Network, .
Comprehensive molecular characterization of gastric adenocarcinoma.
Nature. 513:202–209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cristescu R, Lee J, Nebozhyn M, Kim KM,
Ting JC, Wong SS, Liu J, Yue YG, Wang J, Yu K, et al: Molecular
analysis of gastric cancer identifies subtypes associated with
distinct clinical outcomes. Nat Med. 21:449–456. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mao Z, Pan L, Wang W, Sun J, Shan S, Dong
Q, Liang X, Dai L, Ding X, Chen S, et al: Anp32e, a higher
eukaryotic histone chaperone directs preferential recognition for
H2A.Z. Cell Res. 24:389–399. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lorén V, Garcia-Jaraquemada A, Naves JE,
Carmona X, Mañosa M, Aransay AM, Lavin JL, Sánchez I, Cabré E,
Manyé J and Domènech E: ANP32E, a protein involved in
steroid-refractoriness in ulcerative colitis, identified by a
systems biology approach. J Crohns Colitis. 13:351–361. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xiong Z, Ye L, Zhenyu H, Li F, Xiong Y,
Lin C, Wu X, Deng G, Shi W, Song L, et al: ANP32E induces
tumorigenesis of triple-negative breast cancer cells by
upregulating E2F1. Mol Oncol. 12:896–912. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gursoy-Yuzugullu O, Ayrapetov MK and Price
BD: Histone chaperone Anp32e removes H2A.Z from DNA double-strand
breaks and promotes nucleosome reorganization and DNA repair. Proc
Natl Acad Sci USA. 112:7507–7512. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Alatwi HE and Downs JA: Removal of H2A.Z
by INO80 promotes homologous recombination. EMBO Rep. 16:986–994.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Murphy KE, Meng FW, Makowski CE and Murphy
PJ: Genome-wide chromatin accessibility is restricted by ANP32E.
Nat Commun. 11:50632020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mikami Y, Hori T, Kimura H and Fukagawa T:
The functional region of CENP-H interacts with the Nuf2 complex
that localizes to centromere during mitosis. Mol Cell Biol.
25:1958–1970. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y, Tan PY, Handoko YA, Sekar K, Shi
M, Xie C, Jiang XD, Dong QZ, Goh BKP, Ooi LL, et al: NUF2 is a
valuable prognostic biomarker to predict early recurrence of
hepatocellular carcinoma after surgical resection. Int J Cancer.
145:662–670. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Q, Dai SJ, Li H, Dong L and Peng YP:
Silencing of NUF2 inhibits tumor growth and induces apoptosis in
human hepatocellular carcinomas. Asian Pac J Cancer Prev.
15:8623–8629. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Song Z, Wu Y, Yang J, Yang D and Fang X:
Progress in the treatment of advanced gastric cancer. Tumour Biol.
39:10104283177146262017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pellino A, Riello E, Nappo F, Brignola S,
Murgioni S, Djaballah SA, Lonardi S, Zagonel V, Rugge M, Loupakis F
and Fassan M: Targeted therapies in metastatic gastric cancer:
Current knowledge and future perspectives. World J Gastroenterol.
25:5773–5788. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang J, Gao W, Liu H, Yin G, Duan H,
Huang Z and Zhang Y: Up-regulated ANP32E promotes the thyroid
carcinoma cell proliferation and migration via activating
AKT/mTOR/HK2-mediated glycolysis. Gene. 750:1446812020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang L, Li J, Li Y and Pang LB: Hsa-let-7c
exerts an anti-tumor function by negatively regulating ANP32E in
lung adenocarcinoma. Tissue Cell. 65:1013722020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang J, Lan Z, Qiu G, Ren H, Zhao Y, Gu
Z, Li Z, Feng L, He J and Wang C: Over-expression of ANP32E is
associated with poor prognosis of pancreatic cancer and promotes
cell proliferation and migration through regulating β-catenin. BMC
Cancer. 20:10652020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen L, Gao Y, Zhu L, Song H, Zhao L, Liu
A, Zhang G and Shi G: Establishment and characterization of a GES-1
human gastric epithelial cell line stably expressing miR-23a. Oncol
Lett. 16:977–983. 2018.PubMed/NCBI
|
|
22
|
Keates S, Sougioultzis S, Keates AC, Zhao
D, Peek RM Jr, Shaw LM and Kelly CP: cag+ Helicobacter pylori
induce transactivation of the epidermal growth factor receptor in
AGS gastric epithelial cells. J Biol Chem. 276:48127–48134. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Akagi T and Kimoto T: Human cell line
(HGC-27) derived from the metastatic lymph node of gastric cancer.
Acta Med Okayama. 30:215–219. 1976.PubMed/NCBI
|
|
24
|
Motoyama T, Hojo H and Watanabe H:
Comparison of seven cell lines derived from human gastric
carcinomas. Acta Pathol Jpn. 36:65–83. 1986.PubMed/NCBI
|
|
25
|
Xie X, Jiang S and Li X: Nuf2 is a
prognostic-related biomarker and correlated with immune infiltrates
in hepatocellular carcinoma. Front Oncol. 11:6213732021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhai X, Yang Z, Liu X, Dong Z and Zhou D:
Identification of NUF2 and FAM83D as potential biomarkers in
triple-negative breast cancer. PeerJ. 8:e99752020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fu HL and Shao L: Silencing of NUF2
inhibits proliferation of human osteosarcoma Saos-2 cells. Eur Rev
Med Pharmacol Sci. 20:1071–1079. 2016.PubMed/NCBI
|
